Sensus Healthcare Analyst Ratings
Sensus Healthcare Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/10/2023 | 63.84% | Alliance Global Partners | $16.5 → $14.5 | Maintains | Buy |
| 11/04/2022 | 86.44% | Alliance Global Partners | $17.5 → $16.5 | Maintains | Buy |
| 05/06/2022 | 80.79% | HC Wainwright & Co. | $13 → $16 | Maintains | Buy |
| 03/03/2022 | 46.89% | HC Wainwright & Co. | $12 → $13 | Maintains | Buy |
| 02/14/2022 | 35.59% | HC Wainwright & Co. | $10 → $12 | Maintains | Buy |
| 12/02/2021 | 12.99% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 11/05/2021 | 1.69% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 08/06/2021 | -20.9% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 03/01/2021 | -32.2% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
| 02/26/2021 | -32.2% | Roth Capital | $4 → $6 | Maintains | Buy |
| 11/09/2020 | -54.8% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 05/11/2020 | -66.1% | B. Riley Securities | $5.5 → $3 | Maintains | Neutral |
| 05/08/2020 | -43.5% | HC Wainwright & Co. | $8 → $5 | Reiterates | → Buy |
| 11/07/2019 | -37.85% | B. Riley Securities | $14 → $5.5 | Downgrades | Buy → Neutral |
| 09/19/2018 | 12.99% | Maxim Group | $9 → $10 | Maintains | Buy |
| 08/27/2018 | 58.19% | HC Wainwright & Co. | → $14 | Initiates Coverage On | → Buy |
| 08/01/2018 | 41.24% | Roth Capital | → $12.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 02/10/2023 | 63.84% | 联盟全球合作伙伴 | $16.5→$14.5 | 维护 | 买 |
| 11/04/2022 | 86.44% | 联盟全球合作伙伴 | $17.5→$16.5 | 维护 | 买 |
| 05/06/2022 | 80.79% | HC Wainwright公司 | $13→$16 | 维护 | 买 |
| 03/03/2022 | 46.89% | HC Wainwright公司 | $12→$13 | 维护 | 买 |
| 02/14/2022 | 35.59% | HC Wainwright公司 | $10→$12 | 维护 | 买 |
| 12/02/2021 | 12.99% | HC Wainwright公司 | $9→$10 | 维护 | 买 |
| 2021年11月05日 | 1.69% | HC Wainwright公司 | $7→$9 | 维护 | 买 |
| 08/06/2021 | -20.9% | HC Wainwright公司 | $6→$7 | 维护 | 买 |
| 03/01/2021 | -32.2% | HC Wainwright公司 | $4→$6 | 维护 | 买 |
| 02/26/2021 | -32.2% | 罗斯资本 | $4→$6 | 维护 | 买 |
| 11/09/2020 | -54.8% | HC Wainwright公司 | $5→$4 | 维护 | 买 |
| 05/11/2020 | -66.1% | B.莱利证券 | $5.5→$3 | 维护 | 中性 |
| 05/08/2020 | -43.5% | HC Wainwright公司 | $8→$5 | 重申 | →购买 |
| 2019/07/11 | -37.85% | B.莱利证券 | $14→$5.5 | 评级下调 | 购买→中性 |
| 2018年09月19日 | 12.99% | Maxim集团 | $9→$10 | 维护 | 买 |
| 2018年08月27日 | 58.19% | HC Wainwright公司 | →$14 | 开始承保 | →购买 |
| 2018年08月01日 | 41.24% | 罗斯资本 | →$12.5 | 开始承保 | →购买 |
What is the target price for Sensus Healthcare (SRTS)?
人口普查医疗(SRTS)的目标价格是多少？
The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by Alliance Global Partners on February 10, 2023. The analyst firm set a price target for $14.50 expecting SRTS to rise to within 12 months (a possible 63.84% upside). 5 analyst firms have reported ratings in the last year.
联盟全球合作伙伴于2023年2月10日报告了人口普查医疗(纳斯达克：SRTS)的最新目标价。这家分析公司将目标价定为14.50美元，预计SRT将在12个月内升至(可能上涨63.84%)。去年有5家分析公司公布了评级。
What is the most recent analyst rating for Sensus Healthcare (SRTS)?
人口普查医疗(SRTS)的最新分析师评级是多少？
The latest analyst rating for Sensus Healthcare (NASDAQ: SRTS) was provided by Alliance Global Partners, and Sensus Healthcare maintained their buy rating.
纳斯达克：SRTS)的最新分析师评级由联盟全球合作伙伴提供，人口普查医疗维持买入评级。
When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?
人口普查医疗(SRTS)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on February 10, 2023 so you should expect the next rating to be made available sometime around February 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Scount Healthcare的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。人口普查医疗保健的上一次评级是在2023年2月10日提交的，所以你应该预计下一次评级将在2024年2月10日左右的某个时候提供。
Is the Analyst Rating Sensus Healthcare (SRTS) correct?
分析师对人口普查医疗保健(SRTS)的评级正确吗？
While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a maintained with a price target of $16.50 to $14.50. The current price Sensus Healthcare (SRTS) is trading at is $8.85, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的人口普查医疗(SRTS)评级保持不变，目标价在16.50美元至14.50美元之间。目前Scount Healthcare(SRTS)的交易价格为8.85美元，超出了分析师的预测范围。